Stay updated on ENABLE Study: Lanadelumab in HAE Clinical Trial
Sign up to get notified when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.

Latest updates to the ENABLE Study: Lanadelumab in HAE Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new site revision note (v3.4.2) and removed an old operational notice about government funding; these are administrative updates and do not alter study records or user workflows. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check21 days agoChange DetectedThe page adds a government funding lapse notice with links about operating status and shows a new site revision tag (v3.4.1), while the previous revision tag (v3.4.0) is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check28 days agoChange DetectedThe page adds a glossary toggle, color-coded indicators for additions and deletions, and visible revision metadata (e.g., Revision: v3.4.0).SummaryDifference1.0%

- Check42 days agoChange DetectedThe study record versions now show Revision: v3.3.4 added and Revision: v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.3 was added to the record history, and the footer now omits 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'; these are minor site-maintenance updates that do not affect study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedThe Study Record Versions now show a new Revision: v3.3.2 and the removal of Revision: v3.2.0.SummaryDifference0.1%

Stay in the know with updates to ENABLE Study: Lanadelumab in HAE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.